NCT06159452View on ClinicalTrials.gov

Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 9, 2010

Primary Completion Date

December 21, 2010

Study Completion Date

December 21, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

SAR153191-P3 drug product

Pharmaceutical form:Solution for injection-Route of administration:Subcutaneous injection

DRUG

SAR153191-P2 drug product

Pharmaceutical form:Solution for injection-Route of administration:Subcutaneous injection

DRUG

SAR153191-C1F3 drug product

Pharmaceutical form:Solution for injection-Route of administration:Subcutaneous injection

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY